0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ICH Pharmaceutical Stability Testing and Storage Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-20Z17066
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global ICH Pharmaceutical Stability Testing and Storage Service Market Research Report 2024
BUY CHAPTERS

Global ICH Pharmaceutical Stability Testing and Storage Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-20Z17066
Report
November 2025
Pages:155
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ICH Pharmaceutical Stability Testing and Storage Service Market

The global ICH Pharmaceutical Stability Testing and Storage Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Tablet accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
ICH Pharmaceutical Stability Testing and Storage Service leading manufacturers including Selvita, Intertek, SGS, Reading Scientific Services, Almac Group, Sampled, UPM Pharmaceuticals, Pacific BioLabs, Broughton, Tepnel Pharma Services, etc., dominate supply; the top five capture approximately % of global revenue, with Selvita leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global ICH Pharmaceutical Stability Testing and Storage Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of ICH Pharmaceutical Stability Testing and Storage Service Market Report

Report Metric Details
Report Name ICH Pharmaceutical Stability Testing and Storage Service Market
Segment by Type
  • Stability Testing Service
  • Stable Storage Service
Segment by Application
  • Tablet
  • Capsule
  • Injection
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Selvita, Intertek, SGS, Reading Scientific Services, Almac Group, Sampled, UPM Pharmaceuticals, Pacific BioLabs, Broughton, Tepnel Pharma Services, Q1 Scientific, Altasciences, Eurofins, Nelson Labs, Vetter, Alcami, Primera, JC Analytical, BioLink Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the ICH Pharmaceutical Stability Testing and Storage Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the ICH Pharmaceutical Stability Testing and Storage Service Market report?

Ans: The main players in the ICH Pharmaceutical Stability Testing and Storage Service Market are Selvita, Intertek, SGS, Reading Scientific Services, Almac Group, Sampled, UPM Pharmaceuticals, Pacific BioLabs, Broughton, Tepnel Pharma Services, Q1 Scientific, Altasciences, Eurofins, Nelson Labs, Vetter, Alcami, Primera, JC Analytical, BioLink Life Sciences

What are the Application segmentation covered in the ICH Pharmaceutical Stability Testing and Storage Service Market report?

Ans: The Applications covered in the ICH Pharmaceutical Stability Testing and Storage Service Market report are Tablet, Capsule, Injection, Others

What are the Type segmentation covered in the ICH Pharmaceutical Stability Testing and Storage Service Market report?

Ans: The Types covered in the ICH Pharmaceutical Stability Testing and Storage Service Market report are Stability Testing Service, Stable Storage Service

1 Study Coverage
1.1 Introduction to ICH Pharmaceutical Stability Testing and Storage Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Stability Testing Service
1.2.3 Stable Storage Service
1.3 Market Segmentation by Application
1.3.1 Global ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Injection
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Estimates and Forecasts 2020-2031
2.2 Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global ICH Pharmaceutical Stability Testing and Storage Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global ICH Pharmaceutical Stability Testing and Storage Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Stability Testing Service Market Size by Players
3.3.2 Stable Storage Service Market Size by Players
3.4 Global ICH Pharmaceutical Stability Testing and Storage Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type (2020-2031)
6.4 North America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type (2020-2031)
7.4 Europe ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe ICH Pharmaceutical Stability Testing and Storage Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type (2020-2031)
8.4 Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type (2020-2031)
9.4 Central and South America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America ICH Pharmaceutical Stability Testing and Storage Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Market Size by Type (2020-2031)
10.4 Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Selvita
11.1.1 Selvita Corporation Information
11.1.2 Selvita Business Overview
11.1.3 Selvita ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.1.4 Selvita ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.1.5 Selvita ICH Pharmaceutical Stability Testing and Storage Service Revenue by Product in 2024
11.1.6 Selvita ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application in 2024
11.1.7 Selvita ICH Pharmaceutical Stability Testing and Storage Service Revenue by Geographic Area in 2024
11.1.8 Selvita ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
11.1.9 Selvita Recent Developments
11.2 Intertek
11.2.1 Intertek Corporation Information
11.2.2 Intertek Business Overview
11.2.3 Intertek ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.2.4 Intertek ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.2.5 Intertek ICH Pharmaceutical Stability Testing and Storage Service Revenue by Product in 2024
11.2.6 Intertek ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application in 2024
11.2.7 Intertek ICH Pharmaceutical Stability Testing and Storage Service Revenue by Geographic Area in 2024
11.2.8 Intertek ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
11.2.9 Intertek Recent Developments
11.3 SGS
11.3.1 SGS Corporation Information
11.3.2 SGS Business Overview
11.3.3 SGS ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.3.4 SGS ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.3.5 SGS ICH Pharmaceutical Stability Testing and Storage Service Revenue by Product in 2024
11.3.6 SGS ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application in 2024
11.3.7 SGS ICH Pharmaceutical Stability Testing and Storage Service Revenue by Geographic Area in 2024
11.3.8 SGS ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
11.3.9 SGS Recent Developments
11.4 Reading Scientific Services
11.4.1 Reading Scientific Services Corporation Information
11.4.2 Reading Scientific Services Business Overview
11.4.3 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.4.4 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.4.5 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service Revenue by Product in 2024
11.4.6 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application in 2024
11.4.7 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service Revenue by Geographic Area in 2024
11.4.8 Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
11.4.9 Reading Scientific Services Recent Developments
11.5 Almac Group
11.5.1 Almac Group Corporation Information
11.5.2 Almac Group Business Overview
11.5.3 Almac Group ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.5.4 Almac Group ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.5.5 Almac Group ICH Pharmaceutical Stability Testing and Storage Service Revenue by Product in 2024
11.5.6 Almac Group ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application in 2024
11.5.7 Almac Group ICH Pharmaceutical Stability Testing and Storage Service Revenue by Geographic Area in 2024
11.5.8 Almac Group ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
11.5.9 Almac Group Recent Developments
11.6 Sampled
11.6.1 Sampled Corporation Information
11.6.2 Sampled Business Overview
11.6.3 Sampled ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.6.4 Sampled ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.6.5 Sampled Recent Developments
11.7 UPM Pharmaceuticals
11.7.1 UPM Pharmaceuticals Corporation Information
11.7.2 UPM Pharmaceuticals Business Overview
11.7.3 UPM Pharmaceuticals ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.7.4 UPM Pharmaceuticals ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.7.5 UPM Pharmaceuticals Recent Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Corporation Information
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.8.4 Pacific BioLabs ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.8.5 Pacific BioLabs Recent Developments
11.9 Broughton
11.9.1 Broughton Corporation Information
11.9.2 Broughton Business Overview
11.9.3 Broughton ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.9.4 Broughton ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.9.5 Broughton Recent Developments
11.10 Tepnel Pharma Services
11.10.1 Tepnel Pharma Services Corporation Information
11.10.2 Tepnel Pharma Services Business Overview
11.10.3 Tepnel Pharma Services ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.10.4 Tepnel Pharma Services ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Q1 Scientific
11.11.1 Q1 Scientific Corporation Information
11.11.2 Q1 Scientific Business Overview
11.11.3 Q1 Scientific ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.11.4 Q1 Scientific ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.11.5 Q1 Scientific Recent Developments
11.12 Altasciences
11.12.1 Altasciences Corporation Information
11.12.2 Altasciences Business Overview
11.12.3 Altasciences ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.12.4 Altasciences ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.12.5 Altasciences Recent Developments
11.13 Eurofins
11.13.1 Eurofins Corporation Information
11.13.2 Eurofins Business Overview
11.13.3 Eurofins ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.13.4 Eurofins ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.13.5 Eurofins Recent Developments
11.14 Nelson Labs
11.14.1 Nelson Labs Corporation Information
11.14.2 Nelson Labs Business Overview
11.14.3 Nelson Labs ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.14.4 Nelson Labs ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.14.5 Nelson Labs Recent Developments
11.15 Vetter
11.15.1 Vetter Corporation Information
11.15.2 Vetter Business Overview
11.15.3 Vetter ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.15.4 Vetter ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.15.5 Vetter Recent Developments
11.16 Alcami
11.16.1 Alcami Corporation Information
11.16.2 Alcami Business Overview
11.16.3 Alcami ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.16.4 Alcami ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.16.5 Alcami Recent Developments
11.17 Primera
11.17.1 Primera Corporation Information
11.17.2 Primera Business Overview
11.17.3 Primera ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.17.4 Primera ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.17.5 Primera Recent Developments
11.18 JC Analytical
11.18.1 JC Analytical Corporation Information
11.18.2 JC Analytical Business Overview
11.18.3 JC Analytical ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.18.4 JC Analytical ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.18.5 JC Analytical Recent Developments
11.19 BioLink Life Sciences
11.19.1 BioLink Life Sciences Corporation Information
11.19.2 BioLink Life Sciences Business Overview
11.19.3 BioLink Life Sciences ICH Pharmaceutical Stability Testing and Storage Service Product Features and Attributes
11.19.4 BioLink Life Sciences ICH Pharmaceutical Stability Testing and Storage Service Revenue and Gross Margin (2020-2025)
11.19.5 BioLink Life Sciences Recent Developments
12 ICH Pharmaceutical Stability Testing and Storage ServiceIndustry Chain Analysis
12.1 ICH Pharmaceutical Stability Testing and Storage Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ICH Pharmaceutical Stability Testing and Storage Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ICH Pharmaceutical Stability Testing and Storage Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global ICH Pharmaceutical Stability Testing and Storage Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global ICH Pharmaceutical Stability Testing and Storage Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global ICH Pharmaceutical Stability Testing and Storage Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICH Pharmaceutical Stability Testing and Storage Service as of 2024)
 Table 11. Global ICH Pharmaceutical Stability Testing and Storage Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global ICH Pharmaceutical Stability Testing and Storage Service Companies Headquarters
 Table 13. Global ICH Pharmaceutical Stability Testing and Storage Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. ICH Pharmaceutical Stability Testing and Storage Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America ICH Pharmaceutical Stability Testing and Storage Service Growth Accelerators and Market Barriers
 Table 25. North America ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe ICH Pharmaceutical Stability Testing and Storage Service Growth Accelerators and Market Barriers
 Table 27. Europe ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America ICH Pharmaceutical Stability Testing and Storage Service Investment Opportunities and Key Challenges
 Table 31. Central and South America ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Selvita Corporation Information
 Table 35. Selvita Description and Major Businesses
 Table 36. Selvita Product Features and Attributes
 Table 37. Selvita Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Selvita Revenue Proportion by Product in 2024
 Table 39. Selvita Revenue Proportion by Application in 2024
 Table 40. Selvita Revenue Proportion by Geographic Area in 2024
 Table 41. Selvita ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
 Table 42. Selvita Recent Developments
 Table 43. Intertek Corporation Information
 Table 44. Intertek Description and Major Businesses
 Table 45. Intertek Product Features and Attributes
 Table 46. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Intertek Revenue Proportion by Product in 2024
 Table 48. Intertek Revenue Proportion by Application in 2024
 Table 49. Intertek Revenue Proportion by Geographic Area in 2024
 Table 50. Intertek ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
 Table 51. Intertek Recent Developments
 Table 52. SGS Corporation Information
 Table 53. SGS Description and Major Businesses
 Table 54. SGS Product Features and Attributes
 Table 55. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. SGS Revenue Proportion by Product in 2024
 Table 57. SGS Revenue Proportion by Application in 2024
 Table 58. SGS Revenue Proportion by Geographic Area in 2024
 Table 59. SGS ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
 Table 60. SGS Recent Developments
 Table 61. Reading Scientific Services Corporation Information
 Table 62. Reading Scientific Services Description and Major Businesses
 Table 63. Reading Scientific Services Product Features and Attributes
 Table 64. Reading Scientific Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Reading Scientific Services Revenue Proportion by Product in 2024
 Table 66. Reading Scientific Services Revenue Proportion by Application in 2024
 Table 67. Reading Scientific Services Revenue Proportion by Geographic Area in 2024
 Table 68. Reading Scientific Services ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
 Table 69. Reading Scientific Services Recent Developments
 Table 70. Almac Group Corporation Information
 Table 71. Almac Group Description and Major Businesses
 Table 72. Almac Group Product Features and Attributes
 Table 73. Almac Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Almac Group Revenue Proportion by Product in 2024
 Table 75. Almac Group Revenue Proportion by Application in 2024
 Table 76. Almac Group Revenue Proportion by Geographic Area in 2024
 Table 77. Almac Group ICH Pharmaceutical Stability Testing and Storage Service SWOT Analysis
 Table 78. Almac Group Recent Developments
 Table 79. Sampled Corporation Information
 Table 80. Sampled Description and Major Businesses
 Table 81. Sampled Product Features and Attributes
 Table 82. Sampled Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sampled Recent Developments
 Table 84. UPM Pharmaceuticals Corporation Information
 Table 85. UPM Pharmaceuticals Description and Major Businesses
 Table 86. UPM Pharmaceuticals Product Features and Attributes
 Table 87. UPM Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. UPM Pharmaceuticals Recent Developments
 Table 89. Pacific BioLabs Corporation Information
 Table 90. Pacific BioLabs Description and Major Businesses
 Table 91. Pacific BioLabs Product Features and Attributes
 Table 92. Pacific BioLabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Pacific BioLabs Recent Developments
 Table 94. Broughton Corporation Information
 Table 95. Broughton Description and Major Businesses
 Table 96. Broughton Product Features and Attributes
 Table 97. Broughton Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Broughton Recent Developments
 Table 99. Tepnel Pharma Services Corporation Information
 Table 100. Tepnel Pharma Services Description and Major Businesses
 Table 101. Tepnel Pharma Services Product Features and Attributes
 Table 102. Tepnel Pharma Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Tepnel Pharma Services Recent Developments
 Table 104. Q1 Scientific Corporation Information
 Table 105. Q1 Scientific Description and Major Businesses
 Table 106. Q1 Scientific Product Features and Attributes
 Table 107. Q1 Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Q1 Scientific Recent Developments
 Table 109. Altasciences Corporation Information
 Table 110. Altasciences Description and Major Businesses
 Table 111. Altasciences Product Features and Attributes
 Table 112. Altasciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Altasciences Recent Developments
 Table 114. Eurofins Corporation Information
 Table 115. Eurofins Description and Major Businesses
 Table 116. Eurofins Product Features and Attributes
 Table 117. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Eurofins Recent Developments
 Table 119. Nelson Labs Corporation Information
 Table 120. Nelson Labs Description and Major Businesses
 Table 121. Nelson Labs Product Features and Attributes
 Table 122. Nelson Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Nelson Labs Recent Developments
 Table 124. Vetter Corporation Information
 Table 125. Vetter Description and Major Businesses
 Table 126. Vetter Product Features and Attributes
 Table 127. Vetter Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Vetter Recent Developments
 Table 129. Alcami Corporation Information
 Table 130. Alcami Description and Major Businesses
 Table 131. Alcami Product Features and Attributes
 Table 132. Alcami Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Alcami Recent Developments
 Table 134. Primera Corporation Information
 Table 135. Primera Description and Major Businesses
 Table 136. Primera Product Features and Attributes
 Table 137. Primera Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Primera Recent Developments
 Table 139. JC Analytical Corporation Information
 Table 140. JC Analytical Description and Major Businesses
 Table 141. JC Analytical Product Features and Attributes
 Table 142. JC Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. JC Analytical Recent Developments
 Table 144. BioLink Life Sciences Corporation Information
 Table 145. BioLink Life Sciences Description and Major Businesses
 Table 146. BioLink Life Sciences Product Features and Attributes
 Table 147. BioLink Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. BioLink Life Sciences Recent Developments
 Table 149. Raw Materials Key Suppliers
 Table 150. Distributors List
 Table 151. Market Trends and Market Evolution
 Table 152. Market Drivers and Opportunities
 Table 153. Market Challenges, Risks, and Restraints
 Table 154. Research Programs/Design for This Report
 Table 155. Key Data Information from Secondary Sources
 Table 156. Key Data Information from Primary Sources


List of Figures
 Figure 1. ICH Pharmaceutical Stability Testing and Storage Service Product Picture
 Figure 2. Global ICH Pharmaceutical Stability Testing and Storage Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Stability Testing Service Product Picture
 Figure 4. Stable Storage Service Product Picture
 Figure 5. Global ICH Pharmaceutical Stability Testing and Storage Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Tablet
 Figure 7. Capsule
 Figure 8. Injection
 Figure 9. Others
 Figure 10. ICH Pharmaceutical Stability Testing and Storage Service Report Years Considered
 Figure 11. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 13. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Market Share by Region (2020-2031)
 Figure 15. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Stability Testing Service Revenue Market Share by Player in 2024
 Figure 18. Stable Storage Service Revenue Market Share by Player in 2024
 Figure 19. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Market Share by Type (2020-2031)
 Figure 20. Global ICH Pharmaceutical Stability Testing and Storage Service Revenue Market Share by Application (2020-2031)
 Figure 21. North America ICH Pharmaceutical Stability Testing and Storage Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) in 2024
 Figure 23. North America ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe ICH Pharmaceutical Stability Testing and Storage Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) in 2024
 Figure 30. Europe ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 33. France ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 45. India ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America ICH Pharmaceutical Stability Testing and Storage Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) in 2024
 Figure 53. Central and South America ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) in 2024
 Figure 59. South America ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa ICH Pharmaceutical Stability Testing and Storage Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa ICH Pharmaceutical Stability Testing and Storage Service Revenue (2020-2025) & (US$ Million)
 Figure 65. ICH Pharmaceutical Stability Testing and Storage Service Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart